<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id><journal-id journal-id-type="publisher-id">hmg</journal-id><journal-id journal-id-type="hwp">hmg</journal-id><journal-title-group><journal-title>Human Molecular Genetics</journal-title></journal-title-group><issn pub-type="ppub">0964-6906</issn><issn pub-type="epub">1460-2083</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/hmg/ddp460</article-id><article-id pub-id-type="publisher-id">ddp460</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P<sub>2</sub></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ferguson</surname><given-names>Cole J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lenk</surname><given-names>Guy M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Meisler</surname><given-names>Miriam H.</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff><addr-line>Department of Human Genetics</addr-line>, <institution>University of Michigan</institution>, <addr-line>Ann Arbor, MI 48109-5618</addr-line>, <country>USA</country></aff><author-notes><corresp id="cor1"><label>*</label>To whom correspondence should be addressed at: <addr-line>Department of Human Genetics</addr-line>, <institution>University of Michigan Medical School</institution>, <addr-line>4909 Buhl, Ann Arbor, MI 48109-5618</addr-line>, <country>USA</country>. Tel: <phone>+1 7347635546</phone>; Fax: <fax>+1 7347639691</fax>; Email: <email>meislerm@umich.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>12</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>29</day><month>9</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>9</month><year>2009</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>18</volume><issue>24</issue><fpage>4868</fpage><lpage>4878</lpage><history><date date-type="received"><day>10</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>25</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author 2009. Published by Oxford University Press</copyright-statement><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.5/uk/">http://creativecommons.org/licenses/by-nc/2.5/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Mutations affecting the conversion of PI3P to the signaling lipid PI(3,5)P<sub>2</sub> result in spongiform degeneration of mouse brain and are associated with the human disorders Charcot&#x02013;Marie&#x02013;Tooth disease and amyotrophic lateral sclerosis (ALS). We now report accumulation of the proteins LC3-II, p62 and LAMP-2 in neurons and astrocytes of mice with mutations in two components of the PI(3,5)P<sub>2</sub> regulatory complex, <italic>Fig4</italic> and <italic>Vac14</italic>. Cytoplasmic inclusion bodies containing p62 and ubiquinated proteins are present in regions of the mutant brain that undergo degeneration. Co-localization of p62 and LAMP-2 in affected cells indicates that formation or recycling of the autolysosome is impaired. These results establish a role for PI(3,5)P<sub>2</sub> in autophagy in the mammalian central nervous system (CNS) and demonstrate that mutations affecting PI(3,5)P<sub>2</sub> can contribute to inclusion body disease.</p></abstract></article-meta></front><body><sec id="s1" sec-type="intro"><title>INTRODUCTION</title><p>The phosphatidylinositide PI(3,5)P<sub>2</sub> is a low-abundance signaling lipid that is synthesized on the cytoplasmic surface of vesicular organelles in eukaryotic cells from yeast to mammals. PI(3,5)P<sub>2</sub> synthesis and degradation are regulated by a protein complex that includes the PI3P kinase FAB1 (also known as PIP5K3 and PIKfyve), the Pl(3,5)P<sub>2</sub> 5-phosphatase FIG4 and the scaffold protein VAC14 (<xref ref-type="bibr" rid="DDP460C1">1</xref>,<xref ref-type="bibr" rid="DDP460C2">2</xref>). We have described recessive mutations of human <italic>FIG4</italic> (also known as SAC3) in the peripheral nerve disorder Charcot&#x02013;Marie&#x02013;Tooth Type 4J (OMIM 611228) (<xref ref-type="bibr" rid="DDP460C3">3</xref>), and heterozygous deleterious mutations of <italic>FIG4</italic> in &#x0223c;1% of patients with amyotrophic lateral sclerosis (ALS) (<xref ref-type="bibr" rid="DDP460C4">4</xref>). In mouse models, mutations of <italic>Fig4</italic> and <italic>Vac14</italic> result in a 50&#x02013;75% reduction in the levels of PI(3,5)P<sub>2</sub> in cultured fibroblasts and progressive neurodegeneration that begins in fetal life and results in lethality between birth and 6 weeks of age (<xref ref-type="bibr" rid="DDP460C2">2</xref>,<xref ref-type="bibr" rid="DDP460C3">3</xref>,<xref ref-type="bibr" rid="DDP460C5">5</xref>). Affected mice exhibit extensive spongiform degeneration of the central nervous system (CNS) and substantial loss of peripheral neurons from sensory and sympathetic ganglia.</p><p>The PI(3,5)P<sub>2</sub> regulatory complex is located on the vacuolar membrane in yeast, where synthesis and degradation of Pl(3,5)P<sub>2</sub> are tightly coupled (<xref ref-type="bibr" rid="DDP460C2">2</xref>). In yeast, mutations in this regulatory complex result in reduction of PI(3,5)P<sub>2</sub> and enlargement of the vacuole. Mammalian cells do not contain a precise counterpart to the yeast vacuole. Mammalian FAB1 and FIG4 are associated with intracellular vesicles of the early and late endosome (<xref ref-type="bibr" rid="DDP460C6">6</xref>&#x02013;<xref ref-type="bibr" rid="DDP460C8">8</xref>). In mice carrying spontaneous mutations of <italic>Fig4</italic> (pale tremor) and <italic>Vac14</italic> (ingls), the cellular concentration of PI(3,5)P<sub>2</sub> is reduced and there is accumulation of swollen intracellular vacuoles that appear empty of stored material in neurons and in cultured fibroblasts (<xref ref-type="bibr" rid="DDP460C2">2</xref>,<xref ref-type="bibr" rid="DDP460C3">3</xref>). Similarly, cultured fibroblasts from CMT4J patients who are deficient in FIG4 exhibit extensive cytoplasmic vacuolization (<xref ref-type="bibr" rid="DDP460C9">9</xref>). Treatment of mammalian cells with siRNAs to reduce expression of <italic>Fig4</italic> and <italic>FAB1</italic> also results in swollen intracellular vacuoles (<xref ref-type="bibr" rid="DDP460C10">10</xref>). The membrane of the enlarged vesicles in cultured fibroblasts from <italic>Fig4</italic> null mice stains strongly for LAMP-2, a marker of late endosomes and lysosomes (<xref ref-type="bibr" rid="DDP460C3">3</xref>). These previous studies have implicated PI(3,5)P<sub>2</sub> in the regulation of intracellular trafficking in yeast and mammalian cells.</p><p>Current models suggest that PI(3,5)P<sub>2</sub> is synthesized on endosomes and lysosomes in response to specific cargo molecules (<xref ref-type="bibr" rid="DDP460C10">10</xref>). Membrane-bound PI(3,5)P<sub>2</sub> is thought to interact with membrane proteins, and to recruit cytosolic effector proteins required for trafficking cargo. Through these interactions, synthesis of PI(3,5)P<sub>2</sub> directs trafficking of cargo vesicles along the endosome&#x02013;lysosome axis and promotes recycling of membranes to the <italic>trans</italic>-Golgi network (<xref ref-type="bibr" rid="DDP460C7">7</xref>).</p><p>Macroautophagy (autophagy) is a ubiquitous eukaryotic pathway for degrading damaged organelles and long-lived intracellular proteins (<xref ref-type="bibr" rid="DDP460C11">11</xref>). Autophagy provides nutrients during periods of starvation and serves as a quality control mechanism for misfolded proteins. During autophagy, ubiquitin-tagged substrates are sequestered within double-membrane vesicles that are thought to be enriched in PI3P, the precursor of PI(3,5)P<sub>2</sub> (<xref ref-type="bibr" rid="DDP460C12">12</xref>). Completed autophagosomes can fuse directly with lysosomes, or with endosomal vesicles prior to lysosome fusion, in order to deliver substrates for degradation. In yeast, reduction of PI(3,5)P<sub>2</sub> does not appear to affect autophagy (<xref ref-type="bibr" rid="DDP460C10">10</xref>). In mammalian cells, autophagy is dependent on maturation of early endosomes (<xref ref-type="bibr" rid="DDP460C13">13</xref>). In view of the established role of PI(3,5)P<sub>2</sub> in endosomal trafficking, we hypothesized that reduced levels of PI(3,5)P<sub>2</sub> might affect the progression of autophagy in mammalian cells, and that the resulting impairment of autophagy could be responsible for the extensive neurodegeneration in the PI(3,5)P<sub>2</sub>-deficient mutants <italic>Fig4</italic> (pale tremor) and <italic>Vac14</italic> (ingls).</p><p>The work described here directly tests the hypothesis that there is a block in autophagy in <italic>Fig4</italic> and <italic>Vac14</italic> mutant mice. Our data support and extend the evidence that PI(3,5)P<sub>2</sub> is an essential component of the autophagy pathway. We demonstrate that impaired autophagy underlies neurodegeneration in these mutant mice and is likely to contribute to related human disorders.</p></sec><sec id="s2" sec-type="results"><title>RESULTS</title><sec id="s2a"><title>Autophagy markers in <italic>Fig4</italic><sup>&#x02212;/&#x02212;</sup> brain</title><p>p62/SQSTM1 binds polyubiquinated protein substrates destined for autophagic degradation. Using western blotting, we assessed the amount of p62 in <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> null mice. A significant increase in abundance of p62 was observed in brain and spinal cord (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F1">1</xref>A). The abundance of p62 in 10 &#x000b5;g of mutant brain is comparable with that in 30 &#x000b5;g of wild-type brain, indicating that p62 is increased 3-fold in the mutant (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F1">1</xref>A). Analysis of brain RNA by qRT-PCR demonstrated that the level of p62 transcript is not elevated (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F1">1</xref>B). p62 accumulation is limited to brain and spinal cord, and was not observed in liver or other non-neural tissues (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F1">1</xref>C).</p><fig id="DDP460F1" position="float"><label>Figure&#x000a0;1.</label><caption><p>Markers of autophagy are elevated in brain from <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> brain. Total brain homogenates were examined by western blotting with antibodies to components of the autophagy pathway. (<bold>A</bold>) Accumulation of p62 in mutant brain and spinal cord (left and middle panels); quantitative comparison (right panel). (<bold>B</bold>) qRT-PCR analysis of p62 transcript, relative to the Tata-binding protein transcript, in total brain RNA. Mean &#x000b1; SD (<italic>n</italic> = 3 mice of each genotype, assayed in quadruplicate). (<bold>C</bold>) Normal levels of p62 protein in non-neural tissues. (<bold>D</bold>) Elevation of LC3-II in mutant brain. (<bold>E</bold>) Normal level of LC3-I in mutant brain [short exposure of the film in (D)]. (A)&#x02013;(C) 30 &#x000b5;g protein per lane; (D)&#x02013;(E) 50 &#x000b5;g protein per lane.</p></caption><graphic xlink:href="ddp46001"/></fig><p>LC3-II (MAP1LC3), a component of the autophagosome membrane that binds p62, is generated by conjugation of phosphatidylethanolamine to the cytosolic protein LC3-I, resulting in faster electrophoretic mobility. Elevated LC3-II, but not LC3-I, is a consequence of defective autophagosome clearance (<xref ref-type="bibr" rid="DDP460C14">14</xref>). Examination of brain homogenates by western blotting demonstrated an increase in the level of LC3-II in the <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mutant (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F1">1</xref>D). There is no change in cytoplasmic LC3-I (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F1">1</xref>E). The increased levels of p62 and LC3-II indicate that the process of autophagy is altered in PI(3,5)P<sub>2</sub>-deficient <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> mice.</p></sec><sec id="s2b"><title>Autophagy is not up-regulated in mutant brain</title><p>The accumulation of LC3-II could result either from an elevated rate of basal autophagy, as observed in some lysosomal storage disorders, or from a block in the completion of autophagy. To distinguish between these, we examined the abundance of several proteins involved in the initiation of autophagy. Beclin-1 is a subunit of the class III PI3-kinase complex that is required for autophagosome formation. In <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> brain, the level of beclin-1 protein was comparable to that of wild type (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F2">2</xref>A). Mammalian target of rapamycin (mTOR) is an important regulator of autophagy that is elevated in some lysosomal storage disorders. In mutant brain, we observed normal levels of Ser2448-phosphorylated and total mTOR (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F2">2</xref>B and C). We also examined phosphorylated p70 S6 kinase (p-S6K), an intermediate in regulation by mTOR. The level of p-S6K was normal in the mutant brain (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F2">2</xref>D). These data indicate that the accumulation of autophagy intermediates in <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> brain is likely to result from a block in completion of basal autophagy rather than up-regulation of the pathway.</p><fig id="DDP460F2" position="float"><label>Figure&#x000a0;2.</label><caption><p>Normal levels of proteins involved in initiation and mTOR-mediated regulation of autophagy. (<bold>A</bold>) beclin-1; (<bold>B</bold>) mTOR; (<bold>C</bold>) Ser2448 phospho-mTOR; (<bold>D</bold>) phosphorylated p70 S6 kinase, a downstream target of mTORC1. Thirty micrograms of protein per lane.</p></caption><graphic xlink:href="ddp46002"/></fig></sec><sec id="s2c"><title>p62 and ubiquitin in inclusion bodies</title><p>Insoluble protein aggregates containing p62 and ubiquitin are a common feature of several types of neurodegenerative disease (<xref ref-type="bibr" rid="DDP460C15">15</xref>). To determine whether the elevated p62 in <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> brain is associated with ubiquitinated protein, brain slices were immunostained for p62 and ubiquitin. Co-localization of p62 and ubiquitin was evident in sections of the cortex (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F3">3</xref>A) and other regions of the brain. Both p62 and ubiquitin are associated with densely stained intracellular inclusions that sometimes extended into cell processes (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F3">3</xref>B and C). Ultrastructural analysis of the brainstem revealed numerous electron-dense cytoplasmic vesicles that range in diameter from 0.25 to 4 &#x000b5;m (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F3">3</xref>D) and resemble those in other neurodegenerative disorders (<xref ref-type="bibr" rid="DDP460C15">15</xref>). Consistent with localization of p62 in inclusion bodies, a significant proportion of p62 is pelleted by centrifugation of mutant brain homogenates at 15 000<italic>g</italic> (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F3">3</xref>E).</p><fig id="DDP460F3" position="float"><label>Figure&#x000a0;3.</label><caption><p>p62 is co-localized with ubiquitin in intracellular inclusion bodies. (<bold>A</bold>) Two-color immunofluorescence of cortical sections from <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> mouse demonstrates co-localization of ubiquitin and p62. (<bold>B</bold> and <bold>C</bold>) Peroxidase immunostaining detects immunodense cytoplasmic inclusion bodies containing p62 and ubiquitin in mutant brain that are not present in wild-type controls. (<bold>D</bold>) Ultrastructure (TEM) of <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> brainstem at 7 days of age. (<bold>E</bold>) Western blot of soluble protein and 15 000<italic>g</italic> pellet from brain homogenates prepared in radioimmunoprecipitation buffer. Thirty micrograms of protein per lane.</p></caption><graphic xlink:href="ddp46003"/></fig></sec><sec id="s2d"><title>Inclusion bodies do not contain TDP-43</title><p>In some forms of ALS, the nuclear DNA-binding protein TDP-43 is co-localized in cytoplasmic inclusion bodies that contain p62 and ubiquitin (<xref ref-type="bibr" rid="DDP460C16">16</xref>&#x02013;<xref ref-type="bibr" rid="DDP460C18">18</xref>). We did not detect any increase in TDP-43 protein in <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> brain by western blot (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S1A</ext-link>). Immunostaining revealed normal nuclear localization of TDP-43 (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplemental Material, Fig. S1B</ext-link>), and lack of co-localization with cytoplasmic p62 (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S1C</ext-link>). The data indicate that TDP-43 is not involved in the neuropathology in <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice.</p></sec><sec id="s2e"><title>Astrocytes exhibit high levels of p62</title><p>To identify the cells containing p62 in <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> brain, we co-immunostained brain sections for p62 and cell-specific markers. Extensive overlap was observed when cortical sections were stained for p62 and the astrocyte marker GFAP (glial fibrillary acidic protein) (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F4">4</xref>A). In wild-type brain, the levels of p62 and GFAP were low and no overlap was detected. In mutant cerebellum, immunostaining detected high levels of p62 in Bergmann glia (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F4">4</xref>B and <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S2</ext-link>). These cells reside at the border between the molecular and granule cell layers of the cerebellum and their projections extend to excitatory synapses of the Purkinje cell dendritic arbor. Consistent with the intensity of immunostaining, western blotting demonstrated significant accumulation of both full-length and degraded GFAP (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F4">4</xref>C).</p><fig id="DDP460F4" position="float"><label>Figure&#x000a0;4.</label><caption><p>Accumulation of p62 in reactive astrocytes and neurons of <italic>Fig4</italic><sup>&#x02212;/&#x02212;</sup> brain. (<bold>A</bold>) Immunostaining of cortical sections demonstrates co-localization of p62 and GFAP, an astrocyte marker. (<bold>B</bold>) p62 accumulation in GFAP-positive Bergmann glia in mutant cerebellum; see also <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S2</ext-link>. (<bold>C</bold>) Western blot demonstrates increased abundance of full-length GFAP and degradation products in mutant brain; 30 &#x000b5;g protein per lane. (<bold>D</bold>) Lack of p62 accumulation in astrocytes in the CA1 region of the hippocampus from <italic>Fig4<sup>+/+</sup></italic> epileptic brain. (<bold>E</bold>) Neurons were identified with antibody to the nuclear marker NeuN. Only a small number of NeuN-labeled nuclei are associated with cytoplasmic p62 (insert, arrowheads). (<bold>F</bold>) Most of the p62 in this section is localized in GFAP-positive astrocytes, as also seen in (A).</p></caption><graphic xlink:href="ddp46004"/></fig><p>To investigate the temporal relationship between spongiform degeneration and the appearance of p62-containing astrocytes, we examined <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> brain at 1 week of age, when a small amount of degeneration is visible in the thalamus and brain stem but not in cortex (<xref ref-type="bibr" rid="DDP460C3">3</xref>). Co-staining of p62 and GFAP was evident in the thalamus, but not in the cortex (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F5">5</xref> and <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S3</ext-link>). p62-positive astrocytes were also present in the axonal tracts near the cerebellar nuclei (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F5">5</xref>), a region that is severely affected at later stages (<xref ref-type="bibr" rid="DDP460C3">3</xref>) (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S3</ext-link>). Thus, the appearance of p62-positive astrocytes accompanies the earliest signs of neurodegeneration, consistent with a primary role in pathogenesis.</p><fig id="DDP460F5" position="float"><label>Figure&#x000a0;5.</label><caption><p>p62-containing astrocytes in <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> brain at 1 week of age. (<bold>A</bold>) Accumulation of p62 in GFAP-positive astrocytes in the thalamus, which exhibits spongiform degeneration at 1 week of age (<xref ref-type="bibr" rid="DDP460C3">3</xref>). (<bold>B</bold>) Accumulation of p62 in white matter tracts around the cerebellar nuclei, a site of extensive spongiform degeneration in older animals. (<bold>C</bold>) The cortex is unaffected at P7 (<xref ref-type="bibr" rid="DDP460C3">3</xref>).</p></caption><graphic xlink:href="ddp46005"/></fig><p>As a control for the specificity of p62 accumulation in <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> astrocytes, we examined <italic>Fig4<sup>+/+</sup></italic> astrocytes in Q54 mice, a model of temporal lobe epilepsy with hippocampal sclerosis (<xref ref-type="bibr" rid="DDP460C19">19</xref>). Intensely staining GFAP-positive astrocytes are present in the CA1 region of Q54 hippocampus, but these astrocytes do not contain high levels of p62 (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F4">4</xref>D). Thus, p62 accumulation is not a general feature of astrocytosis, but is specific to <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> brain.</p></sec><sec id="s2f"><title>p62 in neurons and other types of glia</title><p>To assess the accumulation of p62 in neurons, brain slices were co-stained for p62 and NeuN, a marker of neuronal nuclei. A small number of neurons contain cytoplasmic p62 surrounding the NeuN-positive nucleus (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F4">4</xref>E, insert). However, the major portion of p62 staining is in astrocytes (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F4">4</xref>F), as also discussed above.</p><p>Oligodendrocytes were identified by <italic>in situ</italic> hybridization with a cDNA probe for MAG (myelin-associated glycoprotein). MAG-positive cells did not contain p62 (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S4B</ext-link>). Microglia were identified by immunostaining with the marker Iba1. Numerous microglia were present in mutant brain, suggestive of activation by ongoing neuronal damage (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material, Fig. S4</ext-link>B). However, there was no overlap of immunostaining for Iba1 and p62. Thus, the major site of p62 accumulation is in astrocytes, with a small contribution from neurons.</p></sec><sec id="s2g"><title>Co-localization of LAMP-2 and p62 in astrocytes</title><p>LAMP-2 is a highly glycosylated membrane protein that is localized to vesicles of the late endosome and lysosome (<xref ref-type="bibr" rid="DDP460C20">20</xref>). We previously demonstrated the presence of LAMP-2 in the limiting membrane of the cytoplasmic vacuoles in cultured fibroblasts from <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> mice (<xref ref-type="bibr" rid="DDP460C3">3</xref>). Western blot analysis of total brain homogenate revealed significant elevation of LAMP-2 in mutant brain (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F6">6</xref>A). The abundance of LAMP-2 in 10 &#x000b5;g of mutant brain is comparable with that in 30 &#x000b5;g of wild-type brain (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F6">6</xref>A). The elevation of LAMP-2 is thus &#x0223c;3-fold, similar to the elevation of p62 (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F1">1</xref>A).</p><fig id="DDP460F6" position="float"><label>Figure&#x000a0;6.</label><caption><p>Accumulation of LAMP-2 in <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> brain. LAMP-2 is a major component of lysosomal membranes, and is also present in late endosomes and autophagosomes. (<bold>A</bold>) Western blot demonstrates accumulation of LAMP-2 in mutant brain (left panel) with quantitative comparison (right panel). (<bold>B</bold>) LAMP-2 is concentrated in GFAP-positive astrocytes and not in NeuN-poistive neurons. (<bold>C</bold>) Co-localization of LAMP-2 and p62. (<bold>D</bold>) High-resolution confocal imaging (&#x000d7;180) demonstrates subcellular co-localization of LAMP-2 and p62. (<bold>E</bold>) In cultured cerebellar granule neurons from <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> mice, soma and processes (insert) are filled with LAMP-2-positive vacuoles.</p></caption><graphic xlink:href="ddp46006"/></fig><p>To determine which cells accumulate LAMP-2, we co-stained cortical sections for LAMP-2 and cell-specific markers. The majority of LAMP-2 staining was localized to GFAP-positive astrocytes (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F6">6</xref>B). LAMP-2 is thus accumulating in the same cells that accumulate p62 and ubiquinated protein (Figs&#x000a0;<xref ref-type="fig" rid="DDP460F3">3</xref> and <xref ref-type="fig" rid="DDP460F6">6</xref>). High magnification confocal imaging demonstrated co-localization of p62 and LAMP-2 in intracellular vesicles (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F6">6</xref>D).</p></sec><sec id="s2h"><title>LAMP-2 positive vesicles in cultured <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> neurons</title><p>We previously described neuronal vacuolization in sensory ganglia, thalamus, brain stem and ventral spinal cord of <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> brain (<xref ref-type="bibr" rid="DDP460C3">3</xref>). Because only a few vacuolized neurons are visible in brain sections, we examined LAMP-2 staining of neuronal vacuoles using cultured neurons. Cerebellar granule cells were isolated from <italic>Fig4</italic><sup>&#x02212;/&#x02212;</sup> mice at postnatal day 3 and cultured for 11 days as described (<xref ref-type="bibr" rid="DDP460C21">21</xref>). Approximately 25% of the cultured neurons exhibit extensive vacuolization with LAMP-2 staining of vacuoles. In the most severely affected neurons, vacuoles filled the soma and neuronal processes (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F6">6</xref>E). The dramatic appearance of these cells suggests that the first step in pathogenesis may be neuronal cell death due to extensive vacuolization, followed sequentially by a defective astrocyte response and spongiform degeneration.</p></sec><sec id="s2i"><title>Abnormal autophagy in <italic>Vac14</italic> mice mutant</title><p>VAC14 is a component of the PI(3,5)P<sub>2</sub> regulatory complex that acts as a scaffold protein and binds directly to FIG4 and the kinase FAB1 (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F7">7</xref>A). The <italic>Vac14</italic><sup><italic>L156R</italic></sup> mutation in the mouse mutant <italic>ingls</italic> disrupts the interaction with FAB1, resulting in reduced PI(3,5)P<sub>2</sub> and neurodegeneration that mimic the <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> phenotype (<xref ref-type="bibr" rid="DDP460C2">2</xref>). We therefore examined the <italic>ingls</italic> mouse as an independent test of the hypothesis that reduced PI(3,5)P<sub>2</sub> leads to abnormal autophagy.</p><fig id="DDP460F7" position="float"><label>Figure&#x000a0;7.</label><caption><p>Impaired autophagy and astrocytosis in a second mouse mutant affecting PI(3,5)P<sub>2</sub>. (<bold>A</bold>) The protein VAC14 binds FIG4 and FAB1 kinase in the molecular complex that regulates PI(3,5)P<sub>2</sub> synthesis. The Vac14-L156R mutation (red) in the <italic>ingls</italic> mutant mouse results in destabilization of the complex and reduced levels of PI(3,5)P<sub>2</sub> (<xref ref-type="bibr" rid="DDP460C2">2</xref>). (<bold>B</bold>) Elevated levels of p62 and LC3-II in brain homogenates from Vac14-mutant mice. Each lane contains 30 &#x000b5;g of protein. (<bold>C</bold>) Co-localization of p62 and ubiquitin in <italic>ingls</italic> cortex. (<bold>D</bold>) Accumulation of p62 in astrocytes and neurons. (<bold>E</bold>) Accumulation of LAMP-2 in <italic>ingls</italic> brain; 30 &#x000b5;g protein per lane.</p></caption><graphic xlink:href="ddp46007"/></fig><p>Examination of brain homogenates by western blotting demonstrated elevated levels of both p62 and LC3-II in <italic>ingls</italic> brain (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F7">7</xref>B). The p62 is co-localized with ubiquitin in brain sections from the <italic>ingls</italic> mouse (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F7">7</xref>C). Numerous activated astrocytes containing p62 were detected by immunostaining (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F7">7</xref>D). A small proportion of neurons in the <italic>ingls</italic> brain was positive for p62 (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F7">7</xref>D, insert, arrowheads). LAMP-2 is also elevated in <italic>ingls</italic> brain (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F7">7</xref>E). Overall, the accumulation and cellular location of autophagy markers in the <italic>ingls</italic> mutant closely resembles those of <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> mice, supporting the view that the deficiency of PI(3,5)P<sub>2</sub> is responsible for defective autophagy and neurodegeneration in both mutants.</p></sec></sec><sec id="s3" sec-type="discussion"><title>DISCUSSION</title><sec id="s3a"><title>Autophagy and PI(3,5)P<sub>2</sub></title><p>In yeast, mutations of the PI(3,5)P<sub>2</sub> regulatory complex result in enlargement of the vacuole organelle, but do not interfere with autophagy (<xref ref-type="bibr" rid="DDP460C10">10</xref>). However, in <italic>Drosophila</italic> and in <italic>Caenorhabditis elegans</italic>, mutation of the <italic>FAB1</italic> component of the regulatory complex led to accumulation of the LC3 homologs (<xref ref-type="bibr" rid="DDP460C22">22</xref>,<xref ref-type="bibr" rid="DDP460C23">23</xref>), indicating that this pathway has diverged between yeast and higher organisms. The present report is directed toward the role of PI(3,5)P<sub>2</sub> signaling in mammalian autophagy <italic>in vivo</italic>. In two independent mouse mutants deficient in PI(3,5)P<sub>2</sub>, elevated levels of the autophagy markers LC3-II and p62, were detected in brain. Induction of autophagic flux is often accompanied by elevation of LC3-II levels and reduced levels of p62 (<xref ref-type="bibr" rid="DDP460C24">24</xref>). In mutant brain, the level of p62 is greatly <italic>increased</italic> and several proteins involved in regulation of autophagy are not altered. These observations indicate that the predominant effect of deficient PI(3,5)P<sub>2</sub> is to block the progression of autophagy. This view is supported by the recent observation that inhibition of FAB1 in cultured cells results in accumulation of LC3-II (<xref ref-type="bibr" rid="DDP460C25">25</xref>). Our data do not rule out the possibility that there may also be some mTOR-independent induction of basal autophagy.</p><p>The accumulated p62 in mutant brain is located in insoluble inclusion bodies that also contain ubiquitinated protein. Inclusion bodies containing p62 and ubiquitin are characteristic of several types of neurodegenerative disease (<xref ref-type="bibr" rid="DDP460C26">26</xref>). It is clear that nervous system is particularly susceptible to reduction of PI(3,5)P<sub>2</sub><italic>in vivo</italic>, since other tissues do not exhibit cellular vacuolization or accumulation of autophagy intermediates.</p><p>Two models for the specific role of PI(3,5)P<sub>2</sub> in autophagy may be considered (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F8">8</xref>). In the first model, PI(3,5)P<sub>2</sub> is located on the membranes of autophagosomes, late endosomes and/or lysosomes, where it serves as a molecular signal for vesicle fusion leading to mature autolysosomes. Deficiency of PI(3,5)P<sub>2</sub> on these membranes could slow or prevent vesicle fusion events (Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F8">8</xref>-1), leading to accumulation of vesicles containing p62. An alternate model is that PI(3,5)P<sub>2</sub> is required for recycling of the autolysosome membrane after fusion of the amphisome with the lysosome (Fig.&#x000a0;8-2). In this model, autophagy intermediates could accumulate due to the deficiency of membrane components required for continued generation and maturation of autophagosomes. The second model is comparable with the effect of PI(3,5)P<sub>2</sub> deficiency in yeast, where the enlarged vacuole appears to result from failure of vacuole fission and budding (<xref ref-type="bibr" rid="DDP460C10">10</xref>). The second model is supported by the co-localization of p62 with LAMP-2, which implies that vesicle fusion has occurred. The two alternative models are not mutually exclusive, and both steps may be impaired in PI(3,5)P<sub>2</sub>-deficient mice. The progression of autophagy in the mutant mice may be only partially blocked, since mutant fibroblasts contain residual PI(3,5)P<sub>2</sub> and many tissues, including liver, do not exhibit degeneration (<xref ref-type="bibr" rid="DDP460C2">2</xref>). Definitive understanding of the role of PI(3,5)P<sub>2</sub> in this pathway will require more detailed information regarding the precise localization of PI(3,5)P<sub>2</sub> and its regulatory complex in mammalian cells.</p><fig id="DDP460F8" position="float"><label>Figure&#x000a0;8.</label><caption><p>Schematic depiction of maturation and resolution of the autophagosome. (<bold>A</bold>) Proteins that accumulate in brain of pale tremor (<italic>Fig4</italic>) and ingls (<italic>Vac14</italic>) mutant mice. (<bold>B</bold>) Model of maturation of autophagic vesicles, with two potential sites of slowdown or blockage that could explain the accumulation of autophagosome and lysosome marker proteins.</p></caption><graphic xlink:href="ddp46008"/></fig></sec><sec id="s3b"><title>Roles of neurons and astrocytes</title><p>Accumulation of membrane-bounded vesicles in neurons of the CNS and peripheral nervous system was found to be an early feature of neurodegeneration in <italic>Fig4</italic> and <italic>Vac14</italic> mutant mice (<xref ref-type="bibr" rid="DDP460C2">2</xref>,<xref ref-type="bibr" rid="DDP460C3">3</xref>). The current work demonstrates that the majority of accumulated p62 in mutant brain is located within astrocytes. Astrocytes comprise a majority of cells in the CNS, and regulate reuptake of glutamate from excitatory synapses and response to neuronal injury (<xref ref-type="bibr" rid="DDP460C27">27</xref>). Abnormal astrocytes are present as early as 1 week of age, specifically in brain regions that later exhibit the greatest degeneration. Thus, both neurons and astrocytes are affected early in disease progression, and conditional inactivation will be required to separate their contributions. The data are consistent with a model of pathogenesis in which the initiating event is vesicle accumulation and death of neurons, followed by recruitment of astroctyes which are unable to respond adequately to the injury, leading to local neurotoxicity and generation of the empty spaces characteristic of spongiform degeneration. This model is supported by the dramatic accumulation of LAMP-2-positive vacuoles in soma and processes of neurons in culture. The small number of p62-positive neurons visible in brain sections may reflect the short survival time of neurons after the start of vacuolization. The vulnerability of neurons may be related to their postmitotic state, since accumulated vesicles are not diluted by distribution to daughter cells during cell division. The high level of membrane turnover in neurons is thought to contribute to the unique dependence of neurons on autophagy.</p><p>Astrocytes and Bergmann glia in the <italic>Fig4</italic> and <italic>Vac14</italic> mutant brains exhibit morphological features of activation such as hypertrophy, elongated processes, and high GFAP content. The detection of increased GFAP on western blots of whole brain homogenates demonstrates the high level of astrocytosis in the degenerating brains. p62 accumulates in astrocytes of <italic>Fig4</italic> or <italic>Vac14</italic> mutant mice, but not in a model of seizure-induced astrocytosis.</p><p>The relative contribution of neurons and astrocytes to the development of ALS has been evaluated in the mouse model of SOD1-dependent ALS. Both <italic>FIG4</italic> and <italic>SOD1</italic> are ubiquitously expressed &#x02018;housekeeping genes&#x02019; in which certain missense mutations result in late-onset neurodegenerative disease. p62/ubiquitin inclusion bodies are observed in both neurons and astrocytes of mice carrying ALS-associated mutations of SOD1. Global expression of mutant SOD1 transgenes in the mouse recapitulates the human disease, but tissue-specific transgene expression in astrocytes does not itself induce disease (<xref ref-type="bibr" rid="DDP460C28">28</xref>). Tissue-specific expression in neurons is pathogenic if expression is sufficiently high (<xref ref-type="bibr" rid="DDP460C29">29</xref>,<xref ref-type="bibr" rid="DDP460C30">30</xref>). Using conditional knock-out technology, tissue-specific knock-out of mutant SOD1 expression in astrocytes was shown to delay disease progression (<xref ref-type="bibr" rid="DDP460C31">31</xref>). Recapitulation of the SOD1 mutant phenotype requires interaction between neurons, astrocytes, microglia and, possibly, other cell types. In <italic>Fig4<sup>&#x02212;/&#x02212;</sup></italic> mice, affected cells include neurons, astrocytes, and Schwann cells (<xref ref-type="bibr" rid="DDP460C3">3</xref>,<xref ref-type="bibr" rid="DDP460C9">9</xref>). Future application of the conditional knock-out approach will permit dissection of the contributions of these and other cell types to PI(3,5)P<sub>2</sub>-deficient neuropathology.</p></sec><sec id="s3c"><title>Autophagy and neurological disease</title><p>The combination of p62/ubiquitin-positive inclusion bodies and neurodegeneration may result from three distinct categories of gene mutations. The most extensively studied are dominantly inherited mutations in substrates of autophagy that produce &#x02018;toxic&#x02019; proteins that accumulate because they are resistant to degradation. Examples include LRRK2 and PARKIN in Parkinson's disease, SOD1 and TDP-43 in ALS, and the expanded polyglutamine repeat-containing huntingtin protein. In these cases, the mutant protein is a major component of the inclusion bodies, and accumulation of the mutant protein is the cause of degeneration.</p><p>The lysosomal diseases represent a second category of neurodegeneration with p62/ubiquitin inclusion bodies. In these disorders, mutation of a lysosomal enzyme or ion-channel interferes with protein degradation, resulting in back-up accumulation of autophagy intermediates (<xref ref-type="bibr" rid="DDP460C32">32</xref>). Up-regulation of the autophagy pathway is observed in these disorders, apparently as an attempt to compensate for the accumulation of non-degraded proteins.</p><p>We propose that mutations that directly affect components of the autophagy machinery may be considered a third category of inclusion-body-related neurodegenerative disease, and that the <italic>Fig4</italic> and <italic>Vac14</italic> mutations affecting PI(3,5)P<sub>2</sub> fall into this category. Accumulation within neurons of proteins that are normally degraded by autophagy is likely to mediate neuronal cell death. Neuron-specific inactivation of the autophagy proteins ATG5 and ATG7 generates a pattern of neurodegeneration and accumulation of p62/ubiquitin inclusion bodies very similar to those described here (<xref ref-type="bibr" rid="DDP460C33">33</xref>,<xref ref-type="bibr" rid="DDP460C34">34</xref>). Other neurodegenerative disorders that may directly affect autophagy are Chorea acanthocytosis due to mutation of the endosomal protein Soi3 (VPS13a), which interacts with FAB1 (<xref ref-type="bibr" rid="DDP460C35">35</xref>,<xref ref-type="bibr" rid="DDP460C36">36</xref>), and ALS with Frontotemporal Dementia due to mutation of the CHMP2B subunit of the ESCRT complex (<xref ref-type="bibr" rid="DDP460C37">37</xref>,<xref ref-type="bibr" rid="DDP460C38">38</xref>).</p><p>p62/ubiquitin inclusion bodies are a hallmark of ALS. Detection of p62/ubiquitin inclusions in <italic>Fig4</italic>-deficient mice supports our recent report that heterozygosity for partial or complete loss-of-function alleles of <italic>FIG4</italic> may be a risk factor for ALS (<xref ref-type="bibr" rid="DDP460C4">4</xref>). The importance of autophagy in ALS pathogenesis is also supported by recent evidence that increasing autophagy <italic>via</italic> XBP-1 deficiency protects against SOD1-induced ALS in the mouse (<xref ref-type="bibr" rid="DDP460C39">39</xref>).</p><p>The current work suggests that defective autophagy is a potential target for treatment of patients with mutations in <italic>FIG4</italic>. Induction of autophagy is also protective against the toxicity of mutant huntingtin in cultured neurons and <italic>in vivo</italic> (<xref ref-type="bibr" rid="DDP460C40">40</xref>,<xref ref-type="bibr" rid="DDP460C41">41</xref>). Long-term <italic>in vivo</italic> treatment with rapamycin, another inducer of autophagy, is well tolerated in the mouse and leads to extended lifespan (<xref ref-type="bibr" rid="DDP460C42">42</xref>). Drugs that increase the abundance of PI3K may induce autophagy in part by increasing the substrate for conversion of PI3P to PI(3,5)P<sub>2</sub>. In addition to suggesting therapeutic approaches, our observations indicate that other genes encoding components of the autophagy machinery should be evaluated for their role in inherited neurodegenerative disorders.</p></sec></sec><sec id="s4" sec-type="methods"><title>MATERIALS AND METHODS</title><sec id="s4a"><title>Animals</title><p>The pale tremor mutant, <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>, is derived from a spontaneous mutant that arose on a mixed inbred background (<xref ref-type="bibr" rid="DDP460C3">3</xref>). <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice are maintained as a recombinant inbred strain that was derived from an F2 cross with strain CAST/EiJ. The line is maintained by brother &#x000d7; sister mating of heterozygous carriers, and is now at generation N10. The <italic>ingls</italic> mutant (infantile gliosis) carrying the Vac14<sup>L156R</sup> mutation arose on strain DBA/2J and is maintained as a congenic line on strain C57BL/6J (<xref ref-type="bibr" rid="DDP460C2">2</xref>). The congenic line B6.D2-<italic>Vac14</italic><sup><italic>ingls</italic></sup>/J (N23) was obtained from the Jackson Laboratory (stock number 003095). Experiments were carried out on <italic>Fig4</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice between 3 and 4 weeks of age, unless otherwise indicated, and <italic>ingls</italic> mice at 2 weeks of age. The Q54 mice with temporal lobe epilepsy due to a mutation in sodium channel <italic>Scn2a</italic> are maintained on the C57BL/6J background (N15) (<xref ref-type="bibr" rid="DDP460C19">19</xref>). Frozen brain from affected Q54 (B6.Q54XSJL/J)F1 mice was provided by Jennifer Kearney (Vanderbilt University). Animals were housed and cared for in accordance with NIH guidelines, and experiments were approved by the University of Michigan Committee on Use and Care of Animals.</p></sec><sec id="s4b"><title>Western blot analysis</title><p>Tissue homogenates (10%, weight/volume) were prepared by homogenization with a Polytron homogenizer in radioimmunoprecipitation (RIPA) buffer (150 m<sc>m</sc> NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS in 25 m<sc>m</sc> Tris, pH 7.5) containing complete EDTA-free protease inhibitor cocktail (Roche) and 1:1000 &#x003b2;-mercaptoethanol. Homogenates were centrifuged at 15 000<italic>g</italic>. Protein concentration was determined in triplicate using the bicinchoninic acid protein assay reagent (Pierce Chem.) Pellets were resuspended in RIPA buffer using the Polytron homogenizer. Samples were boiled for 3 min in the presence of &#x003b2;-mercaptoethanol prior to electrophoresis on precast 4&#x02013;20% SDS-PAGE gels (Criterion) and transfer to Hybond nitrocellulose membranes (Amersham Biosciences). Membranes were pre-incubated for 1 h at room temperature in western blocking solution, 1% BSA fraction V (Fischer Scientific) with 5% powdered milk (Amresco) in TBST (Tris-buffered saline with Tween 20). Primary antibody incubation was carried out overnight at 4&#x000b0;C. Guinea pig anti-p62 (American Research Products) was used at 1:1000, rabbit anti-LC3 (Novus Biologicals) at 1:500, anti-TDP-43 (Proteintech Group) at 1:500, rat anti-LAMP2 (ABL-93 concentrate fraction, Iowa Hybridoma bank) at 1:1000, rabbit anti-GFAP (Abcam) at 1:1000, rabbit anti-Beclin-1 (Santa Cruz) at 1:1000 and rabbit anti-mTOR (Cell Signaling) at 1:1000. Membranes were blocked in 3% BSA prior to staining with mouse anti-GAPDH (1:30,000, Abcam), rabbit anti phospho-p70S6 kinase (1:250, Cell Signaling) and rabbit phospho-mTOR Ser2448 (1:1000, Cell Signaling). Membranes were washed in TBST and incubated with peroxidase-labeled secondary antibodies for 1 h at room temperature. Chemiluminescence was detected with the Supersignal West Femto chemiluminescence reagent (Pierce) and Hybond-CL autoradiography film (Denville Scientific).</p></sec><sec id="s4c"><title>Quantitation of p62/SQSTM1 mRNA</title><p>RNA was extracted from whole brain (<italic>n</italic> = 3 for each genotype) using the TriZol reagent (Invitrogen). cDNA was generated using oligo-dT primers with the SuperScript first-strand synthesis RT-PCR kit (Invitrogen). Expression was measured using predesigned TaqMan assay probes (<uri xlink:type="simple" xlink:href="www.appliedbiosystems.com">www.appliedbiosystems.com</uri>) with analysis on a StepOne Plus&#x000a0; real-time PCR system (ABI). Each sample was assayed in quadruplicate and expression of p62/SQSTM1 was normalized to the Tata binding protein (<italic>Tbp</italic>).</p></sec><sec id="s4d"><title>Immunocytochemistry</title><p>Fresh frozen saggital cryosections (10 &#x000b5;m) were dried at room temp for 20 min, fixed in fresh 3.2% paraformaldehyde (Pierce) for 20 min, permeabilized with 0.2% Triton X-100 and blocked in 10% goat serum. Primary antibody to p62 (1:200 mouse anti-p62, Abnova H00008878-M01) or ubiquitin (or 1:200 rabbit anti-ubiquitin, DAKO) was applied and sections were incubated overnight at 4&#x000b0;C in 5% goat serum. Peroxidase-diaminobenzidine staining was carried out with the Histostain kit (Zymed). Brightfield images were captured on an Olympus BX51 microscope equipped with Olympus DP-70 digital camera.</p></sec><sec id="s4e"><title>Immunofluorescence</title><p>Brain sections were prepared as above. The concentration of primary antibodies was 1:200 mouse anti-p62 (Abnova), 1:500 rabbit anti-GFAP (Abcam), 1:100 rabbit anti-TDP-43 (Proteintech Group), 1:250 rabbit anti-Iba1 (Wako Pure Chemical Industries), 1:200 rabbit anti-ubiquitin (Dako) and 1:5000 rat anti-LAMP-2 (ABL-93 concentrate). Prior to staining with anti-Iba1 and anti-LAMP-2, sections were treated with 0.2% Saponin (Sigma). Secondary detection was carried out with antibodies conjugated to Alexa 488 or Alexa 594 (Invitrogen) at dilutions of 1:500 to 1:1000. For immunofluorescence in the blue range, rabbit primary antibodies were detected with 1:500 biotin-conjugated goat anti-rabbit (Invitrogen) and 1:500 Neutravidin Alexa 350 (Invitrogen). Mouse monoclonal anti-NeuN conjugated to Alexa 488 (Millipore) was applied to sections at 1:100 after secondary detection of mouse anti-p62. Images were captured on an Olympus BX51 microscope equipped with epifluorescence and an Olympus DP-70 digital camera. Images were processed and merged using Adobe Photoshop software. A Zeiss LSM 510-META laser scanning confocal microscope was used for imaging Fig.&#x000a0;<xref ref-type="fig" rid="DDP460F6">6</xref>D and E.</p></sec><sec id="s4f"><title>Ultrastructure</title><p>Mice were perfused with 2.5% glutaraldehyde, and tissue was processed for electron microscopy as described previously (<xref ref-type="bibr" rid="DDP460C43">43</xref>).</p></sec></sec><sec id="s5"><title>AUTHOR CONTRIBUTIONS</title><p>C.J.F., G.M.L. and M.H.M. designed experiments, analyzed results and wrote the manuscript. C.J.F. and G.M.L carried out the experiments. M.H.M. directed the project.</p></sec><sec id="s6"><title>SUPPLEMENTARY MATERIAL</title><p><ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/cgi/content/full/ddp460/DC1">Supplementary Material is available at <italic>HMG</italic> online</ext-link>.</p></sec><sec id="s7"><title>FUNDING</title><p>This work was supported by <funding-source>NIH</funding-source> research grant <award-id>R01 GM24872</award-id> (M.H.M.), <funding-source>Medical Sciences Training Program</funding-source><award-id>T32 GM07863</award-id> (C.J.F.), <funding-source>Training Program in Systems and Integrative Biology</funding-source><award-id>T32 GM008322</award-id> (C.J.F.) and a postdoctoral fellowship from the <funding-source>Hartwell Foundation</funding-source> (G.M.L.). Funding to pay the Open Access publication charges for this article was provided by the <funding-source>NIH</funding-source>.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>[Supplementary Data]</title></caption><media mimetype="text" mime-subtype="html" xlink:href="ddp460_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="ddp460_1.pdf"/></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We thank Roman Giger for assistance with MAG <italic>in situ</italic> hybridization, Clement Chow and Julie Jones for preparation of tissues for electron microscopy, and Jennifer Kearney for tissue from Q54 mice. We also thank Dan Klionsky, Andrew Lieberman, Matthew Elrick and Robert Fuller for helpful discussions and critical review of the manuscript.</p><p><italic>Conflict of Interest Statement</italic>. None declared.</p></ack><ref-list><title>REFERENCES</title><ref id="DDP460C1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duex</surname><given-names>J.E.</given-names></name><name><surname>Tang</surname><given-names>F.</given-names></name><name><surname>Weisman</surname><given-names>L.S.</given-names></name></person-group><article-title>The Vac14p&#x02013;Fig4p complex acts independently of Vac7p and couples PI3,5P2 synthesis and turnover</article-title><source>J. Cell Biol.</source><year>2006</year><volume>172</volume><fpage>693</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">16492811</pub-id></element-citation></ref><ref id="DDP460C2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>N.</given-names></name><name><surname>Chow</surname><given-names>C.Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Zolov</surname><given-names>S.N.</given-names></name><name><surname>Bronson</surname><given-names>R.</given-names></name><name><surname>Davisson</surname><given-names>M.</given-names></name><name><surname>Petersen</surname><given-names>J.L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Duex</surname><given-names>J.E.</given-names></name><etal/></person-group><article-title>VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse</article-title><source>EMBO J.</source><year>2008</year><volume>27</volume><fpage>3221</fpage><lpage>3234</lpage><pub-id pub-id-type="pmid">19037259</pub-id></element-citation></ref><ref id="DDP460C3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>C.Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Dowling</surname><given-names>J.J.</given-names></name><name><surname>Jin</surname><given-names>N.</given-names></name><name><surname>Adamska</surname><given-names>M.</given-names></name><name><surname>Shiga</surname><given-names>K.</given-names></name><name><surname>Szigeti</surname><given-names>K.</given-names></name><name><surname>Shy</surname><given-names>M.E.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17572665</pub-id></element-citation></ref><ref id="DDP460C4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>C.Y.</given-names></name><name><surname>Landers</surname><given-names>J.E.</given-names></name><name><surname>Bergren</surname><given-names>S.K.</given-names></name><name><surname>Sapp</surname><given-names>P.C.</given-names></name><name><surname>Grant</surname><given-names>A.E.</given-names></name><name><surname>Jones</surname><given-names>J.M.</given-names></name><name><surname>Everett</surname><given-names>L.</given-names></name><name><surname>Lenk</surname><given-names>G.M.</given-names></name><name><surname>McKenna-Yasek</surname><given-names>D.M.</given-names></name><name><surname>Weisman</surname><given-names>L.S.</given-names></name><etal/></person-group><article-title>Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS</article-title><source>Am. J. Hum. Genet.</source><year>2009</year><volume>84</volume><fpage>85</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">19118816</pub-id></element-citation></ref><ref id="DDP460C5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zolov</surname><given-names>S.N.</given-names></name><name><surname>Chow</surname><given-names>C.Y.</given-names></name><name><surname>Slutsky</surname><given-names>S.G.</given-names></name><name><surname>Richardson</surname><given-names>S.C.</given-names></name><name><surname>Piper</surname><given-names>R.C.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Nau</surname><given-names>J.J.</given-names></name><name><surname>Westrick</surname><given-names>R.J.</given-names></name><name><surname>Morrison</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>17518</fpage><lpage>17523</lpage><pub-id pub-id-type="pmid">17956977</pub-id></element-citation></ref><ref id="DDP460C6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikonomov</surname><given-names>O.C.</given-names></name><name><surname>Sbrissa</surname><given-names>D.</given-names></name><name><surname>Shisheva</surname><given-names>A.</given-names></name></person-group><article-title>Localized PtdIns 3,5-P2 synthesis to regulate early endosome dynamics and fusion</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2006</year><volume>291</volume><fpage>C393</fpage><lpage>C404</lpage><pub-id pub-id-type="pmid">16510848</pub-id></element-citation></ref><ref id="DDP460C7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutherford</surname><given-names>A.C.</given-names></name><name><surname>Traer</surname><given-names>C.</given-names></name><name><surname>Wassmer</surname><given-names>T.</given-names></name><name><surname>Pattni</surname><given-names>K.</given-names></name><name><surname>Bujny</surname><given-names>M.V.</given-names></name><name><surname>Carlton</surname><given-names>J.G.</given-names></name><name><surname>Stenmark</surname><given-names>H.</given-names></name><name><surname>Cullen</surname><given-names>P.J.</given-names></name></person-group><article-title>The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport</article-title><source>J. Cell Sci.</source><year>2006</year><volume>119</volume><fpage>3944</fpage><lpage>3957</lpage><pub-id pub-id-type="pmid">16954148</pub-id></element-citation></ref><ref id="DDP460C8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sbrissa</surname><given-names>D.</given-names></name><name><surname>Ikonomov</surname><given-names>O.C.</given-names></name><name><surname>Fu</surname><given-names>Z.</given-names></name><name><surname>Ijuin</surname><given-names>T.</given-names></name><name><surname>Gruenberg</surname><given-names>J.</given-names></name><name><surname>Takenawa</surname><given-names>T.</given-names></name><name><surname>Shisheva</surname><given-names>A.</given-names></name></person-group><article-title>Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>23878</fpage><lpage>23891</lpage><pub-id pub-id-type="pmid">17556371</pub-id></element-citation></ref><ref id="DDP460C9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Chow</surname><given-names>C.Y.</given-names></name><name><surname>Sahenk</surname><given-names>Z.</given-names></name><name><surname>Shy</surname><given-names>M.E.</given-names></name><name><surname>Meisler</surname><given-names>M.H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration</article-title><source>Brain</source><year>2008</year><volume>131</volume><fpage>1990</fpage><lpage>2001</lpage><pub-id pub-id-type="pmid">18556664</pub-id></element-citation></ref><ref id="DDP460C10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dove</surname><given-names>S.K.</given-names></name><name><surname>Dong</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Williams</surname><given-names>F.K.</given-names></name><name><surname>Michell</surname><given-names>R.H.</given-names></name></person-group><article-title>Phosphatidylinositol 3,5-bisphosphate and Fab1p/PIKfyve underPPIn endo-lysosome function</article-title><source>Biochem. J.</source><year>2009</year><volume>419</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">19272020</pub-id></element-citation></ref><ref id="DDP460C11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klionsky</surname><given-names>D.J.</given-names></name></person-group><article-title>Autophagy: from phenomenology to molecular understanding in less than a decade</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2007</year><volume>8</volume><fpage>931</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">17712358</pub-id></element-citation></ref><ref id="DDP460C12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axe</surname><given-names>E.L.</given-names></name><name><surname>Walker</surname><given-names>S.A.</given-names></name><name><surname>Manifava</surname><given-names>M.</given-names></name><name><surname>Chandra</surname><given-names>P.</given-names></name><name><surname>Roderick</surname><given-names>H.L.</given-names></name><name><surname>Habermann</surname><given-names>A.</given-names></name><name><surname>Griffiths</surname><given-names>G.</given-names></name><name><surname>Ktistakis</surname><given-names>N.T.</given-names></name></person-group><article-title>Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum</article-title><source>J. Cell Biol.</source><year>2008</year><volume>182</volume><fpage>685</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">18725538</pub-id></element-citation></ref><ref id="DDP460C13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razi</surname><given-names>M.</given-names></name><name><surname>Chan</surname><given-names>E.Y.</given-names></name><name><surname>Tooze</surname><given-names>S.A.</given-names></name></person-group><article-title>Early endosomes and endosomal coatomer are required for autophagy</article-title><source>J. Cell Biol.</source><year>2009</year><volume>185</volume><fpage>305</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">19364919</pub-id></element-citation></ref><ref id="DDP460C14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klionsky</surname><given-names>D.J.</given-names></name><name><surname>Abeliovich</surname><given-names>H.</given-names></name><name><surname>Agostinis</surname><given-names>P.</given-names></name><name><surname>Agrawal</surname><given-names>D.K.</given-names></name><name><surname>Aliev</surname><given-names>G.</given-names></name><name><surname>Askew</surname><given-names>D.S.</given-names></name><name><surname>Baba</surname><given-names>M.</given-names></name><name><surname>Baehrecke</surname><given-names>E.H.</given-names></name><name><surname>Bahr</surname><given-names>B.A.</given-names></name><name><surname>Ballabio</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes</article-title><source>Autophagy</source><year>2008</year><volume>4</volume><fpage>151</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">18188003</pub-id></element-citation></ref><ref id="DDP460C15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuusisto</surname><given-names>E.</given-names></name><name><surname>Kauppinen</surname><given-names>T.</given-names></name><name><surname>Alafuzoff</surname><given-names>I.</given-names></name></person-group><article-title>Use of p62/SQSTM1 antibodies for neuropathological diagnosis</article-title><source>Neuropathol. Appl. Neurobiol.</source><year>2008</year><volume>34</volume><fpage>169</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">17961133</pub-id></element-citation></ref><ref id="DDP460C16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>I.F.</given-names></name><name><surname>Wu</surname><given-names>L.S.</given-names></name><name><surname>Shen</surname><given-names>C.K.</given-names></name></person-group><article-title>TDP-43: an emerging new player in neurodegenerative diseases</article-title><source>Trends Mol. Med.</source><year>2008</year><volume>14</volume><fpage>479</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">18929508</pub-id></element-citation></ref><ref id="DDP460C17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.J.</given-names></name><name><surname>Xu</surname><given-names>Y.F.</given-names></name><name><surname>Cook</surname><given-names>C.</given-names></name><name><surname>Gendron</surname><given-names>T.F.</given-names></name><name><surname>Roettges</surname><given-names>P.</given-names></name><name><surname>Link</surname><given-names>C.D.</given-names></name><name><surname>Lin</surname><given-names>W.L.</given-names></name><name><surname>Tong</surname><given-names>J.</given-names></name><name><surname>Castanedes-Casey</surname><given-names>M.</given-names></name><name><surname>Ash</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>7607</fpage><lpage>7612</lpage><pub-id pub-id-type="pmid">19383787</pub-id></element-citation></ref><ref id="DDP460C18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sreedharan</surname><given-names>J.</given-names></name><name><surname>Blair</surname><given-names>I.P.</given-names></name><name><surname>Tripathi</surname><given-names>V.B.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Vance</surname><given-names>C.</given-names></name><name><surname>Rogelj</surname><given-names>B.</given-names></name><name><surname>Ackerley</surname><given-names>S.</given-names></name><name><surname>Durnall</surname><given-names>J.C.</given-names></name><name><surname>Williams</surname><given-names>K.L.</given-names></name><name><surname>Buratti</surname><given-names>E.</given-names></name><etal/></person-group><article-title>TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis</article-title><source>Science</source><year>2008</year><volume>319</volume><fpage>1668</fpage><lpage>1672</lpage><pub-id pub-id-type="pmid">18309045</pub-id></element-citation></ref><ref id="DDP460C19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>J.A.</given-names></name><name><surname>Plummer</surname><given-names>N.W.</given-names></name><name><surname>Smith</surname><given-names>M.R.</given-names></name><name><surname>Kapur</surname><given-names>J.</given-names></name><name><surname>Cummins</surname><given-names>T.R.</given-names></name><name><surname>Waxman</surname><given-names>S.G.</given-names></name><name><surname>Goldin</surname><given-names>A.L.</given-names></name><name><surname>Meisler</surname><given-names>M.H.</given-names></name></person-group><article-title>A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities</article-title><source>Neuroscience</source><year>2001</year><volume>102</volume><fpage>307</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">11166117</pub-id></element-citation></ref><ref id="DDP460C20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskelinen</surname><given-names>E.L.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Saftig</surname><given-names>P.</given-names></name></person-group><article-title>At the acidic edge: emerging functions for lysosomal membrane proteins</article-title><source>Trends Cell Biol.</source><year>2003</year><volume>13</volume><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">12628346</pub-id></element-citation></ref><ref id="DDP460C21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharkey</surname><given-names>L.M.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Drews</surname><given-names>V.</given-names></name><name><surname>Buchner</surname><given-names>D.A.</given-names></name><name><surname>Jones</surname><given-names>J.M.</given-names></name><name><surname>Justice</surname><given-names>M.J.</given-names></name><name><surname>Waxman</surname><given-names>S.G.</given-names></name><name><surname>Dib-Hajj</surname><given-names>S.D.</given-names></name><name><surname>Meisler</surname><given-names>M.H.</given-names></name></person-group><article-title>The ataxia3 mutation in the N-terminal cytoplasmic domain of sodium channel Na(v)1.6 disrupts intracellular trafficking</article-title><source>J. Neurosci.</source><year>2009</year><volume>29</volume><fpage>2733</fpage><lpage>2741</lpage><pub-id pub-id-type="pmid">19261867</pub-id></element-citation></ref><ref id="DDP460C22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusten</surname><given-names>T.E.</given-names></name><name><surname>Vaccari</surname><given-names>T.</given-names></name><name><surname>Lindmo</surname><given-names>K.</given-names></name><name><surname>Rodahl</surname><given-names>L.M.</given-names></name><name><surname>Nezis</surname><given-names>I.P.</given-names></name><name><surname>Sem-Jacobsen</surname><given-names>C.</given-names></name><name><surname>Wendler</surname><given-names>F.</given-names></name><name><surname>Vincent</surname><given-names>J.P.</given-names></name><name><surname>Brech</surname><given-names>A.</given-names></name><name><surname>Bilder</surname><given-names>D.</given-names></name><etal/></person-group><article-title>ESCRTs and Fab1 regulate distinct steps of autophagy</article-title><source>Curr. Biol.</source><year>2007</year><volume>17</volume><fpage>1817</fpage><lpage>1825</lpage><pub-id pub-id-type="pmid">17935992</pub-id></element-citation></ref><ref id="DDP460C23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicot</surname><given-names>A.S.</given-names></name><name><surname>Fares</surname><given-names>H.</given-names></name><name><surname>Payrastre</surname><given-names>B.</given-names></name><name><surname>Chisholm</surname><given-names>A.D.</given-names></name><name><surname>Labouesse</surname><given-names>M.</given-names></name><name><surname>Laporte</surname><given-names>J.</given-names></name></person-group><article-title>The phosphoinositide kinase PIKfyve/Fab1p regulates terminal lysosome maturation in <italic>Caenorhabditis elegans</italic></article-title><source>Mol. Biol. Cell</source><year>2006</year><volume>17</volume><fpage>3062</fpage><lpage>3074</lpage><pub-id pub-id-type="pmid">16801682</pub-id></element-citation></ref><ref id="DDP460C24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N.</given-names></name><name><surname>Yoshimori</surname><given-names>T.</given-names></name></person-group><article-title>How to interpret LC3 immunoblotting</article-title><source>Autophagy</source><year>2007</year><volume>3</volume><fpage>542</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">17611390</pub-id></element-citation></ref><ref id="DDP460C25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lartigue</surname><given-names>J.</given-names></name><name><surname>Polson</surname><given-names>H.</given-names></name><name><surname>Feldman</surname><given-names>M.</given-names></name><name><surname>Shokat</surname><given-names>K.</given-names></name><name><surname>Tooze</surname><given-names>S.A.</given-names></name><name><surname>Urbe</surname><given-names>S.</given-names></name><name><surname>Clague</surname><given-names>M.J.</given-names></name></person-group><article-title>PIKfyve regulation of endosome-linked pathways</article-title><source>Traffic</source><year>2009</year><volume>10</volume><fpage>883</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">19582903</pub-id></element-citation></ref><ref id="DDP460C26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>C.A.</given-names></name><name><surname>Poirier</surname><given-names>M.A.</given-names></name></person-group><article-title>Protein aggregation and neurodegenerative disease</article-title><source>Nat. Med.</source><year>2004</year><volume>10</volume><issue>suppl.</issue><fpage>S10</fpage><lpage>S17</lpage><pub-id pub-id-type="pmid">15272267</pub-id></element-citation></ref><ref id="DDP460C27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbeito</surname><given-names>L.H.</given-names></name><name><surname>Pehar</surname><given-names>M.</given-names></name><name><surname>Cassina</surname><given-names>P.</given-names></name><name><surname>Vargas</surname><given-names>M.R.</given-names></name><name><surname>Peluffo</surname><given-names>H.</given-names></name><name><surname>Viera</surname><given-names>L.</given-names></name><name><surname>Estevez</surname><given-names>A.G.</given-names></name><name><surname>Beckman</surname><given-names>J.S.</given-names></name></person-group><article-title>A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis</article-title><source>Brain Res. Rev.</source><year>2004</year><volume>47</volume><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">15572176</pub-id></element-citation></ref><ref id="DDP460C28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y.H.</given-names></name><name><surname>Parsadanian</surname><given-names>A.S.</given-names></name><name><surname>Andreeva</surname><given-names>A.</given-names></name><name><surname>Snider</surname><given-names>W.D.</given-names></name><name><surname>Elliott</surname><given-names>J.L.</given-names></name></person-group><article-title>Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration</article-title><source>J. Neurosci.</source><year>2000</year><volume>20</volume><fpage>660</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">10632595</pub-id></element-citation></ref><ref id="DDP460C29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lino</surname><given-names>M.M.</given-names></name><name><surname>Schneider</surname><given-names>C.</given-names></name><name><surname>Caroni</surname><given-names>P.</given-names></name></person-group><article-title>Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease</article-title><source>J. Neurosci.</source><year>2002</year><volume>22</volume><fpage>4825</fpage><lpage>4832</lpage><pub-id pub-id-type="pmid">12077179</pub-id></element-citation></ref><ref id="DDP460C30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaarsma</surname><given-names>D.</given-names></name><name><surname>Teuling</surname><given-names>E.</given-names></name><name><surname>Haasdijk</surname><given-names>E.D.</given-names></name><name><surname>De Zeeuw</surname><given-names>C.I.</given-names></name><name><surname>Hoogenraad</surname><given-names>C.C.</given-names></name></person-group><article-title>Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice</article-title><source>J. Neurosci.</source><year>2008</year><volume>28</volume><fpage>2075</fpage><lpage>2088</lpage><pub-id pub-id-type="pmid">18305242</pub-id></element-citation></ref><ref id="DDP460C31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Chun</surname><given-names>S.J.</given-names></name><name><surname>Boillee</surname><given-names>S.</given-names></name><name><surname>Fujimori-Tonou</surname><given-names>N.</given-names></name><name><surname>Yamashita</surname><given-names>H.</given-names></name><name><surname>Gutmann</surname><given-names>D.H.</given-names></name><name><surname>Takahashi</surname><given-names>R.</given-names></name><name><surname>Misawa</surname><given-names>H.</given-names></name><name><surname>Cleveland</surname><given-names>D.W.</given-names></name></person-group><article-title>Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis</article-title><source>Nat. Neurosci.</source><year>2008</year><volume>11</volume><fpage>251</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">18246065</pub-id></element-citation></ref><ref id="DDP460C32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>C.D.</given-names></name><name><surname>Elrick</surname><given-names>M.J.</given-names></name><name><surname>Lieberman</surname><given-names>A.P.</given-names></name></person-group><article-title>Tau deletion exacerbates the phenotype of Niemann&#x02013;Pick type C mice and implicates autophagy in pathogenesis</article-title><source>Hum. Mol. Genet.</source><year>2009</year><volume>18</volume><fpage>956</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">19074461</pub-id></element-citation></ref><ref id="DDP460C33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Matsui</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>A.</given-names></name><name><surname>Nakahara</surname><given-names>Y.</given-names></name><name><surname>Suzuki-Migishima</surname><given-names>R.</given-names></name><name><surname>Yokoyama</surname><given-names>M.</given-names></name><name><surname>Mishima</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>I.</given-names></name><name><surname>Okano</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>885</fpage><lpage>889</lpage><pub-id pub-id-type="pmid">16625204</pub-id></element-citation></ref><ref id="DDP460C34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>M.</given-names></name><name><surname>Waguri</surname><given-names>S.</given-names></name><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Murata</surname><given-names>S.</given-names></name><name><surname>Iwata</surname><given-names>J.</given-names></name><name><surname>Tanida</surname><given-names>I.</given-names></name><name><surname>Ueno</surname><given-names>T.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Uchiyama</surname><given-names>Y.</given-names></name><name><surname>Kominami</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Loss of autophagy in the central nervous system causes neurodegeneration in mice</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>880</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">16625205</pub-id></element-citation></ref><ref id="DDP460C35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brickner</surname><given-names>J.H.</given-names></name><name><surname>Fuller</surname><given-names>R.S.</given-names></name></person-group><article-title>SOI1 encodes a novel, conserved protein that promotes TGN-endosomal cycling of Kex2p and other membrane proteins by modulating the function of two TGN localization signals</article-title><source>J. Cell Biol.</source><year>1997</year><volume>139</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9314526</pub-id></element-citation></ref><ref id="DDP460C36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rampoldi</surname><given-names>L.</given-names></name><name><surname>Dobson-Stone</surname><given-names>C.</given-names></name><name><surname>Rubio</surname><given-names>J.P.</given-names></name><name><surname>Danek</surname><given-names>A.</given-names></name><name><surname>Chalmers</surname><given-names>R.M.</given-names></name><name><surname>Wood</surname><given-names>N.W.</given-names></name><name><surname>Verellen</surname><given-names>C.</given-names></name><name><surname>Ferrer</surname><given-names>X.</given-names></name><name><surname>Malandrini</surname><given-names>A.</given-names></name><name><surname>Fabrizi</surname><given-names>G.M.</given-names></name><etal/></person-group><article-title>A conserved sorting-associated protein is mutant in chorea-acanthocytosis</article-title><source>Nat. Genet.</source><year>2001</year><volume>28</volume><fpage>119</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">11381253</pub-id></element-citation></ref><ref id="DDP460C37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parkinson</surname><given-names>N.</given-names></name><name><surname>Ince</surname><given-names>P.G.</given-names></name><name><surname>Smith</surname><given-names>M.O.</given-names></name><name><surname>Highley</surname><given-names>R.</given-names></name><name><surname>Skibinski</surname><given-names>G.</given-names></name><name><surname>Andersen</surname><given-names>P.M.</given-names></name><name><surname>Morrison</surname><given-names>K.E.</given-names></name><name><surname>Pall</surname><given-names>H.S.</given-names></name><name><surname>Hardiman</surname><given-names>O.</given-names></name><name><surname>Collinge</surname><given-names>J.</given-names></name><etal/></person-group><article-title>ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)</article-title><source>Neurology</source><year>2006</year><volume>67</volume><fpage>1074</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">16807408</pub-id></element-citation></ref><ref id="DDP460C38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filimonenko</surname><given-names>M.</given-names></name><name><surname>Stuffers</surname><given-names>S.</given-names></name><name><surname>Raiborg</surname><given-names>C.</given-names></name><name><surname>Yamamoto</surname><given-names>A.</given-names></name><name><surname>Malerod</surname><given-names>L.</given-names></name><name><surname>Fisher</surname><given-names>E.M.</given-names></name><name><surname>Isaacs</surname><given-names>A.</given-names></name><name><surname>Brech</surname><given-names>A.</given-names></name><name><surname>Stenmark</surname><given-names>H.</given-names></name><name><surname>Simonsen</surname><given-names>A.</given-names></name></person-group><article-title>Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease</article-title><source>J. Cell Biol.</source><year>2007</year><volume>179</volume><fpage>485</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">17984323</pub-id></element-citation></ref><ref id="DDP460C39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname><given-names>C.</given-names></name><name><surname>Thielen</surname><given-names>P.</given-names></name><name><surname>Matus</surname><given-names>S.</given-names></name><name><surname>Nassif</surname><given-names>M.</given-names></name><name><surname>Court</surname><given-names>F.</given-names></name><name><surname>Kiffin</surname><given-names>R.</given-names></name><name><surname>Martinez</surname><given-names>G.</given-names></name><name><surname>Cuervo</surname><given-names>A.M.</given-names></name><name><surname>Brown</surname><given-names>R.H.</given-names></name><name><surname>Glimcher</surname><given-names>L.H.</given-names></name></person-group><article-title>XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy</article-title><source>Genes Dev.</source><year>2009</year><volume>23</volume><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="DDP460C40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>J.E.</given-names></name><name><surname>Martinez</surname><given-names>R.A.</given-names></name><name><surname>La Spada</surname><given-names>A.R.</given-names></name></person-group><article-title>Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>2363</fpage><lpage>2373</lpage><pub-id pub-id-type="pmid">19017649</pub-id></element-citation></ref><ref id="DDP460C41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Ravikumar</surname><given-names>B.</given-names></name><name><surname>Floto</surname><given-names>R.A.</given-names></name><name><surname>Rubinsztein</surname><given-names>D.C.</given-names></name></person-group><article-title>Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies</article-title><source>Cell Death Differ.</source><year>2009</year><volume>16</volume><fpage>46</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">18636076</pub-id></element-citation></ref><ref id="DDP460C42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>D.E.</given-names></name><name><surname>Strong</surname><given-names>R.</given-names></name><name><surname>Sharp</surname><given-names>Z.D.</given-names></name><name><surname>Nelson</surname><given-names>J.F.</given-names></name><name><surname>Astle</surname><given-names>C.M.</given-names></name><name><surname>Flurkey</surname><given-names>K.</given-names></name><name><surname>Nadon</surname><given-names>N.L.</given-names></name><name><surname>Wilkinson</surname><given-names>J.E.</given-names></name><name><surname>Frenkel</surname><given-names>K.</given-names></name><name><surname>Carter</surname><given-names>C.S.</given-names></name><etal/></person-group><article-title>Rapamycin fed late in life extends lifespan in genetically heterogeneous mice</article-title><source>Nature</source><year>2009</year><volume>460</volume><fpage>331</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">19606132</pub-id></element-citation></ref><ref id="DDP460C43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>J.M.</given-names></name><name><surname>Huang</surname><given-names>J.D.</given-names></name><name><surname>Mermall</surname><given-names>V.</given-names></name><name><surname>Hamilton</surname><given-names>B.A.</given-names></name><name><surname>Mooseker</surname><given-names>M.S.</given-names></name><name><surname>Escayg</surname><given-names>A.</given-names></name><name><surname>Copeland</surname><given-names>N.G.</given-names></name><name><surname>Jenkins</surname><given-names>N.A.</given-names></name><name><surname>Meisler</surname><given-names>M.H.</given-names></name></person-group><article-title>The mouse neurological mutant flailer expresses a novel hybrid gene derived by exon shuffling between Gnb5 and Myo5a</article-title><source>Hum. Mol. Genet.</source><year>2000</year><volume>9</volume><fpage>821</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">10749990</pub-id></element-citation></ref></ref-list></back></article>